Literature DB >> 28400053

Proprotein convertase furin/PCSK3 and atherosclerosis: New insights and potential therapeutic targets.

Kun Ren1, Ting Jiang2, Xi-Long Zheng3, Guo-Jun Zhao4.   

Abstract

Furin, a member of the mammalian proprotein convertases family, can promote the proteolytic maturation of proproteins. It is known that furin is predominantly present in certain cell types of human atherosclerotic lesions and neointima in animal models, including vascular smooth muscle cells, endothelial cells and mononuclear inflammatory cells. Evidence suggests that furin participates in the initiation and progression of atherosclerosis through regulation of lipid and cholesterol metabolism, inflammatory response, blood pressure and the formation of atherosclerotic lesions. This review provides a panorama of the roles of furin in atherosclerosis and the insights into the prevention and treatment of atherosclerosis and cardiovascular disease.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Furin; Inflammation; Lipid metabolism

Mesh:

Substances:

Year:  2017        PMID: 28400053     DOI: 10.1016/j.atherosclerosis.2017.04.005

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  12 in total

Review 1.  Genetic and epigenetic regulation of human aging and longevity.

Authors:  Brian J Morris; Bradley J Willcox; Timothy A Donlon
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-09-01       Impact factor: 5.187

2.  Changes in interleukin-27 levels in patients with acute coronary syndrome and their clinical significance.

Authors:  Lin Zhang; Junfeng Zhang; Shaohong Su; Suyan Luo
Journal:  PeerJ       Date:  2019-01-04       Impact factor: 2.984

3.  Integrated Analysis of Summary Statistics to Identify Pleiotropic Genes and Pathways for the Comorbidity of Schizophrenia and Cardiometabolic Disease.

Authors:  Hao Liu; Yang Sun; Xinxin Zhang; Shiyang Li; Dong Hu; Lei Xiao; Yanghui Chen; Lin He; Dao Wen Wang
Journal:  Front Psychiatry       Date:  2020-04-17       Impact factor: 4.157

Review 4.  COVID-19: Invasion, pathogenesis and possible cure - A review.

Authors:  Nitin P; Nandhakumar R; Vidhya B; Rajesh S; Sakunthala A
Journal:  J Virol Methods       Date:  2021-12-14       Impact factor: 2.014

Review 5.  Why All the Fury over Furin?

Authors:  Essam Eldin A Osman; Alnawaz Rehemtulla; Nouri Neamati
Journal:  J Med Chem       Date:  2021-08-02       Impact factor: 7.446

Review 6.  Mouse Models of Human Proprotein Convertase Insufficiency.

Authors:  Manita Shakya; Iris Lindberg
Journal:  Endocr Rev       Date:  2021-05-25       Impact factor: 19.871

7.  Furin inhibitor protects against neuronal cell death induced by activated NMDA receptors.

Authors:  Mariko Yamada; Hideki Hayashi; Moe Yuuki; Nahoko Matsushima; Bo Yuan; Norio Takagi
Journal:  Sci Rep       Date:  2018-03-26       Impact factor: 4.379

8.  FURIN variant associations with postexercise hypotension are intensity and race dependent.

Authors:  Burak T Cilhoroz; Elizabeth D Schifano; Gregory A Panza; Garrett I Ash; Lauren Corso; Ming-Hui Chen; Ved Deshpande; Amanda Zaleski; Paulo Farinatti; Lucas P Santos; Beth A Taylor; Rachel J O'Neill; Paul D Thompson; Linda S Pescatello
Journal:  Physiol Rep       Date:  2019-02

9.  Beneficial impact of epigallocatechingallate on LDL-C through PCSK9/LDLR pathway by blocking HNF1α and activating FoxO3a.

Authors:  Chuan-Jue Cui; Jing-Lu Jin; Lin-Na Guo; Jing Sun; Na-Qiong Wu; Yuan-Lin Guo; Geng Liu; Qian Dong; Jian-Jun Li
Journal:  J Transl Med       Date:  2020-05-12       Impact factor: 5.531

10.  The association between plasma furin and cardiovascular events after acute myocardial infarction.

Authors:  Zhi-Wei Liu; Qiang Ma; Jie Liu; Jing-Wei Li; Yun-Dai Chen
Journal:  BMC Cardiovasc Disord       Date:  2021-09-27       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.